Dare Bioscience DARE
NASDAQ DARE
$0.85 -0.01 (-0.95%)
As of: Oct 1, 2026 · 12:03 PM EDT

Dare Bioscience (DARE) Preferred Stock Liabilities (2013 - 2014)

Updated

Dare Bioscience's Preferred Stock Liabilities was $81.53 million in Q1 2014, unchanged from the prior quarter.

Analysis

Dare Bioscience (DARE) Preferred Stock Liabilities (2013 - 2014) Analysis & Trends

  • In earlier years, Preferred Stock Liabilities was $83.75 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Dare Bioscience 12.89 Mn -52.57 Mn -132,343.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 81.53 Mn
Dec 31, 2013 81.53 Mn
API Access

Dare Bioscience Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=DARE&period=max&api_key=YOUR_API_KEY